Reagents and kits used in genomics and proteomics include sample preparation kits, electrophoresis kits, purification kits, and microarrays. Analytical tools and technologies include, Next Generation Sequencing (NSG), Mass Spectrometry (MS), thermal cyclers, and chromatography.
The global genomics and proteomics reagents, research kits, and analytical instrumentation market is estimated to account for US$ 59,185.3 Mn in terms of value in 2020 and is expected to reach US$ 132,162.2 Mn by the end of 2027.
Global Genomics and Proteomics Reagents, Research Kits, and Analytical Instrumentation Market: Drivers
Increasing launch of new PCR kits is expected to propel growth of the global genomics and proteomics reagents, research kits, and analytical instrumentation market over the forecast period. For instance, in April 2020, QIAGEN N.V. launched therascreen BRAF V600E RGQ PCR Kit (therascreen BRAF V600E Kit) as a companion diagnostic to the BRAF inhibitor, BRAFTOVI (encorafenib), for use in combination with cetuximab for the treatment of adult patients with metastatic colorectal cancer with a BRAF V600E mutation.
Global Genomics and Proteomics Reagents, Research Kits, and Analytical Instrumentation Market: Opportunities
R&D in NGS is expected to offer lucrative growth opportunities for players in the global genomics and proteomics reagents, research kits, and analytical instrumentation market. For instance, in March 2020, Illumina, Inc. partnered with IDbyDNA Inc., a metagenomics technology company, for R&D of next-generation sequencing-based workflows.
Global Genomics and Proteomics Reagents, Research Kits, and Analytical Instrumentation Market: Restraints
False discovery rate of SNP chips is expected to hinder the market growth. For instance, according to a study published in the journal bioRxiv in June 2019, SNP chips used by direct-to-consumer genetic testing companies have a false discovery rate of over 85% when screening for very rare variants.
Key Takeaways:
The global genomics and proteomics reagents, research kits, and analytical instrumentation market was valued at US$ 52,353.2 Mn in 2019 and is forecast to reach a value of US$ 132,162.2 Mn by 2027 at a CAGR of 12.2% between 2020 and 2027. Major factor driving the growth of global genomics and proteomics reagents, research kits, and analytical instrumentation market during the forecast period include increasing investment in the pharmaceutical sector, and increasing demand for better diagnostic technologies.